| Product NDC: | 0037-2250 |
| Proprietary Name: | Soma |
| Non Proprietary Name: | Carisoprodol |
| Active Ingredient(s): | 250 mg/1 & nbsp; Carisoprodol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0037-2250 |
| Labeler Name: | Meda Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA011792 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070901 |
| Package NDC: | 0037-2250-04 |
| Package Description: | 4 POUCH in 1 BOX (0037-2250-04) > 1 TABLET in 1 POUCH |
| NDC Code | 0037-2250-04 |
| Proprietary Name | Soma |
| Package Description | 4 POUCH in 1 BOX (0037-2250-04) > 1 TABLET in 1 POUCH |
| Product NDC | 0037-2250 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Carisoprodol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20070901 |
| Marketing Category Name | NDA |
| Labeler Name | Meda Pharmaceuticals Inc. |
| Substance Name | CARISOPRODOL |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |